Final dividend 2019 Royal DSM
DSM declares a dividend for the financial year 2019 of €2.40 per ordinary share.
08 May 2020
DSM is a global science-based company operating in the fields of Nutrition, Health and Sustainable Living. Our business is centered around developing innovative solutions and large innovation projects addressing Nutrition & Health, Climate & Energy and Resources & Circularity to drive above market growth.
We have recently celebrated the 30th anniversary of our privitisation and our ordinary shares being listed on the Euronext Stock Exchange in Amsterdam, the Netherlands.
We provide nutritional solutions for animal health and human well-being, serving the global feed, food & beverage, pharmaceutical, infant nutrition, dietary supplements and personal care industries.
2019
Sales: ↑€2,892 (2018: €2,749)
Organic Growth: ↑4%
Volume Growth: ↑2%
Price Growth: ↑2%
2019
Sales: ↑€2,046 (2018: €1,989)
Organic Growth: ↓1%
Volume Growth: ↑2%
Price Growth: ↓3%
2019
Sales: ↑€572 (2018: €490)
Sales: ↑17%
Organic Growth: ↑4
2019
Sales: ↑€425 (2018: €382)
Sales: ↑11%
Organic Growth: ↑9%
1) Underlying business, net of temporary vitamin effect
Advanced and high-performance materials for the electrical & electronics, automotive, packaging, consumer goods, life protection, transportation and telecom industries.
2019
Sales: ↓€1,406 (2018: €1,516)
Organic Growth: ↓10%
2019
Sales: ↓€338 (2018: €344)
Organic Growth: ↓4%
2019
Sales: ↓€1,002 (2018: €1,053)
Organic Growth: ↓6%
DSM declares a dividend for the financial year 2019 of €2.40 per ordinary share.
08 May 2020
DSM held a virtual Annual General Meeting of Shareholders on 8 May 2020 when shareholders approved all resolutions on the agenda.
08 May 2020
DSM reports a solid Q1 2020, suspends overall earnings outlook given current limited visibility in Materials.
07 May 2020
Our Investor Relations team are based in Heerlen, the Netherlands. The team provides key facts and figures, as well as shareholder information, to current and potential shareholders of DSM and to analysts. To that effect Investor Relations plans, prepares and organizes the written and oral communications with (potential) shareholders and financial analysts, deals with the stock exchange authorities and maintains the necessary databases, websites and brochures.?
Dave Huizing
Vice President Investor Relations
+31 45 578 2864
Anna Morello
Investor Relations Manager
+31 45 578 2282
Marc Silvertand
Investor Relations Manager
+31 45 578 2348
Daniel?Uribe
Investor Relations Analyst
+31 45 578 2864
Sandra Segers
Personal Assistant
+31 45 578 2864
Petra Volk
Support Officer
+31 45 578 2511
Key facts and figures about DSM, our business and our people, planet & profit performance in one overview.
An introduction for investors and analysts to DSM, our Nutrition, Materials and Innovation Center clusters and our businesses.
DSM has set two ambitious targets for profit growth and cash generation to drive value creation for the period 2019-2021.